Increased Liver Uptake and Reduced Hepatic Stellate Cell Activation with a Cell-Specific Conjugate of the Rho-kinase Inhibitor Y27632

By Beuge Marike   Prakash Jai   Lacombe Marie   Post Eduard   Reker-Smit Catharina   Beljaars Leonie   Poelstra Klaas  

Pharmaceutical Research, Vol. 28, Iss. 8, 2011-08 ,pp. : 2045-2054

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model

By Takahara A.   Sugiyama A.   Satoh Y.   Yoneyama M.   Hashimoto K.  

European Journal of Pharmacology, Vol. 460, Iss. 1, 2003-01 ,pp. : 51-57

Elsevier

Access to resources Recommend Favorite

Protein kinase C inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice

By Nangle M.R.   Cotter M.A.   Cameron N.E.  

European Journal of Pharmacology, Vol. 475, Iss. 1, 2003-08 ,pp. : 99-106

Elsevier

Access to resources Recommend Favorite

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka   Shimokawa Hiroaki  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Rho-kinase inhibitors show promise in pulmonary hypertension

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1157-1159

Informa Healthcare

Access to resources Recommend Favorite